BURLINGTON, N.C. - Labcorp (NYSE:LH) announced Tuesday it has expanded its molecular residual disease (MRD) testing portfolio to help clinicians detect cancer recurrence earlier than traditional ...
Abstract: The appointment-based school bus service, with its customized, personalized and intelligent service advantages, has become a new service mode for primary and secondary school students' ...
TOLEDO - NAMSA, a medical device testing and regulatory consulting firm, has acquired Labcorp’s (NYSE:LH) Early Development medical device testing business, according to a press release issued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results